Human ZDHHC17/DHHC-17/HIP14 ORF/cDNA clone-Lentivirus plasmid (NM_015336)
Cat. No.: pGMLP002434
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human ZDHHC17/DHHC-17/HIP14 Lentiviral expression plasmid for ZDHHC17 lentivirus packaging, ZDHHC17 lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
HIP14/ZDHHC17/ZDHHC17/DHHC-17 products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP002434 |
| Gene Name | ZDHHC17 |
| Accession Number | NM_015336 |
| Gene ID | 23390 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 1899 bp |
| Gene Alias | DHHC-17,HIP14,HIP3,HSPC294,HYPH |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGCAGCGGGAGGAGGGATTTAACACCAAGATGGCGGACGGCCCGGATGAGTACGATACCGAAGCGGGCTGTGTGCCCCTTCTCCACCCAGAGGAAATCAAACCCCAAAGCCATTATAACCATGGATATGGTGAACCTCTTGGACGGAAAACTCATATTGATGATTACAGCACATGGGACATAGTCAAGGCTACACAATATGGAATATATGAACGCTGTCGAGAATTGGTGGAAGCAGGTTATGATGTACGGCAACCGGACAAAGAAAATGTTACCCTCCTCCATTGGGCTGCCATCAATAACAGAATAGATTTAGTCAAATACTATATTTCGAAAGGTGCTATTGTGGATCAACTTGGAGGGGACCTGAATTCAACTCCATTGCACTGGGCCACAAGACAAGGCCATCTATCCATGGTTGTGCAACTAATGAAATATGGTGCAGATCCTTCATTAATTGATGGAGAAGGATGTAGCTGTATTCATCTGGCTGCTCAGTTCGGACATACCTCAATTGTTGCTTATCTCATAGCAAAAGGACAGGATGTAGATATGATGGATCAGAATGGAATGACGCCTTTAATGTGGGCAGCATATAGAACACATAGTGTGGATCCAACTAGATTGCTTTTAACATTCAATGTTTCAGTTAACCTTGGTGACAAGTATCACAAAAACACTGCTCTGCATTGGGCAGTGCTAGCAGGGAATACCACAGTCATTAGCCTTCTTCTGGAAGCTGGAGCTAATGTTGATGCCCAGAATATCAAGGGCGAATCAGCGCTTGATTTGGCAAAACAGAGAAAAAATGTGTGGATGATCAACCACTTACAAGAGGCAAGGCAAGCAAAAGGATATGACAATCCGTCCTTCCTTAGAAAGCTGAAAGCTGATAAGGAATTTCGGCAGAAAGTAATGTTAGGAACTCCTTTCCTAGTTATTTGGCTGGTTGGGTTTATAGCAGACCTAAATATTGATTCTTGGCTCATTAAAGGGCTAATGTATGGTGGTGTTTGGGCTACAGTACAGTTTCTTTCAAAATCCTTTTTCGATCATTCAATGCATAGTGCATTGCCCCTTGGGATATATTTGGCAACCAAATTCTGGATGTATGTGACGTGGTTCTTCTGGTTTTGGAATGATCTCAACTTTTTATTTATCCATCTTCCATTCCTTGCCAATAGTGTTGCACTTTTCTACAATTTTGGAAAATCTTGGAAATCAGATCCAGGGATTATTAAAGCAACAGAAGAGCAAAAGAAAAAGACAATAGTTGAACTTGCAGAGACAGGAAGTCTGGACCTCAGTATATTCTGCAGTACCTGTTTGATACGAAAACCGGTGAGGTCCAAACATTGTGGTGTGTGCAACCGCTGTATAGCAAAATTTGATCATCATTGCCCATGGGTGGGTAACTGTGTAGGTGCAGGCAACCATAGATATTTTATGGGCTACCTATTCTTCTTGCTTTTTATGATCTGCTGGATGATTTATGGTTGTATATCTTACTGGGGACTCCACTGTGAGACCACTTACACCAAGGATGGATTTTGGACATACATTACTCAGATTGCCACGTGTTCACCTTGGATGTTTTGGATGTTCCTGAACAGTGTTTTCCACTTCATGTGGGTGGCTGTATTACTCATGTGTCAGATGTACCAGATATCATGTTTAGGTATTACTACAAATGAAAGAATGAATGCCAGGAGATACAAGCACTTTAAAGTCACAACAACGTCTATTGAAAGCCCATTCAACCATGGATGTGTAAGAAATATTATAGACTTCTTTGAATTTCGATGCTGTGGCCTCTTTCGTCCTGTTATCGTGGACTGGACCAGGCAGTATACAATAGAATATGACCAAATATCAGGATCTGGGTACCAGCTGGTGTAG |
| ORF Protein Sequence | MQREEGFNTKMADGPDEYDTEAGCVPLLHPEEIKPQSHYNHGYGEPLGRKTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEARQAKGYDNPSFLRKLKADKEFRQKVMLGTPFLVIWLVGFIADLNIDSWLIKGLMYGGVWATVQFLSKSFFDHSMHSALPLGIYLATKFWMYVTWFFWFWNDLNFLFIHLPFLANSVALFYNFGKSWKSDPGIIKATEEQKKKTIVELAETGSLDLSIFCSTCLIRKPVRSKHCGVCNRCIAKFDHHCPWVGNCVGAGNHRYFMGYLFFLLFMICWMIYGCISYWGLHCETTYTKDGFWTYITQIATCSPWMFWMFLNSVFHFMWVAVLLMCQMYQISCLGITTNERMNARRYKHFKVTTTSIESPFNHGCVRNIIDFFEFRCCGLFRPVIVDWTRQYTIEYDQISGSGYQLV |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-IP2304-Ab | Anti-ZDHHC17 monoclonal antibody |
| Target Antigen | GM-Tg-g-IP2304-Ag | ZDHHC17 protein |
| ORF Viral Vector | pGMLP002434 | Human ZDHHC17 Lentivirus plasmid |
| ORF Viral Vector | pGMPC004838 | Human ZDHHC17 Mammalian (Non-Viral Vector) plasmid |
| ORF Viral Vector | vGMLP002434 | Human ZDHHC17 Lentivirus particle |
Target information
| Target ID | GM-IP2304 |
| Target Name | HIP14/ZDHHC17 |
|
Gene Group Identifier (Target Gene ID in Homo species) |
23390 |
| Gene ID |
100059245 (Equus caballus), 101084552 (Felis catus), 23390 (Homo sapiens), 320150 (Mus musculus) 366889 (Rattus norvegicus), 482574 (Canis lupus familiaris), 541172 (Bos taurus), 693595 (Macaca mulatta) |
| Gene Symbols & Synonyms | ZDHHC17,Zdhhc17,HIP3,HYPH,HIP14,DHHC17,DHHC-17,HSPC294,Hip14,A230053P19Rik,D130071N24Rik |
| Target Alternative Names | A230053P19Rik,Acyltransferase ZDHHC17,D130071N24Rik,DHHC domain-containing cysteine-rich protein 17 (DHHC17),DHHC-17,DHHC17,HIP14,HIP3,HSPC294,HYPH,Hip14,Huntingtin yeast partner H,Huntingtin-interacting protein 14 (HIP-14),Huntingtin-interacting protein 3 (HIP-3),Huntingtin-interacting protein H,Palmitoyltransferase ZDHHC17,Putative MAPK-activating protein PM11,Putative NF-kappa-B-activating protein 205,ZDHHC17,Zdhhc17,Zinc finger DHHC domain-containing protein 17 |
| Uniprot Accession |
E9PTT0,Q80TN5,Q8IUH5
Additional SwissProt Accessions: Q8IUH5,Q80TN5,E9PTT0 |
| Uniprot Entry Name | |
| Protein Sub-location | Introcelluar Protein |
| Category | |
| Disease | |
| Disease from KEGG | |
| Gene Ensembl | ENSECAG00000006626, ENSG00000186908, ENSMUSG00000035798, ENSCAFG00845006644, ENSBTAG00000021756, ENSMMUG00000018254 |
| Target Classification |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


